Literature DB >> 23871765

The prevalence of dementia in urban and rural areas of China.

Jianping Jia1, Fen Wang2, Cuibai Wei2, Aihong Zhou2, Xiangfei Jia3, Fang Li4, Muni Tang5, Lan Chu6, Youlong Zhou7, Chunkui Zhou8, Yong Cui9, Qi Wang2, Weishan Wang10, Peng Yin11, Nan Hu11, Xiumei Zuo2, Haiqing Song2, Wei Qin2, Liyong Wu2, Dan Li2, Longfei Jia12, Juexian Song2, Ying Han2, Yi Xing2, Peijie Yang2, Yuemei Li2, Yuchen Qiao2, Yi Tang2, Jihui Lv10, Xiumin Dong2.   

Abstract

OBJECTIVE: The Chinese population has been aging rapidly and the country's economy has experienced exponential growth during the past three decades. The goal of this study was to estimate the changes in the prevalence of dementia, Alzheimer's disease (AD), and vascular dementia (VaD) among elderly Chinese individuals and to analyze differences between urban and rural areas.
METHODS: For the years 2008 to 2009, we performed a population-based cross-sectional survey with a multistage cluster sampling design. Residents aged 65 years and older were drawn from 30 urban (n = 6096) and 45 rural (n = 4180) communities across China. Participants were assessed with a series of clinical examinations and neuropsychological measures. Dementia, AD, and VaD were diagnosed according to established criteria via standard diagnostic procedures.
RESULTS: The prevalence of dementia, AD, and VaD among individuals aged 65 years and older were 5.14% (95% CI, 4.71-5.57), 3.21% (95% CI, 2.87-3.55), and 1.50% (95% CI, 1.26-1.74), respectively. The prevalence of dementia was significantly higher in rural areas than in urban ones (6.05% vs. 4.40%, P < .001). The same regional difference was also seen for AD (4.25% vs. 2.44%, P < .001) but not for VaD (1.28% vs. 1.61%, P = .166). The difference in AD was not evident when the sample was stratified by educational level. Moreover, the risk factors for AD and VaD differed for urban and rural populations.
CONCLUSIONS: A notably higher prevalence of dementia and AD was found in rural areas than in urban ones, and education might be an important reason for the urban-rural differences.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Alzheimer's disease; Dementia; Prevalence; Risk factors; Vascular dementia

Mesh:

Year:  2013        PMID: 23871765     DOI: 10.1016/j.jalz.2013.01.012

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  114 in total

1.  Carotid intima-media thickness and cognitive function in a middle-aged and older adult community: a cross-sectional study.

Authors:  Anxin Wang; Guojuan Chen; Zhaoping Su; Xiaoxue Liu; Xiaodong Yuan; Ruixuan Jiang; Yibin Cao; Shuohua Chen; Yanxia Luo; Xiuhua Guo; Shouling Wu; Xingquan Zhao
Journal:  J Neurol       Date:  2016-07-19       Impact factor: 4.849

2.  Chronic Sleep Restriction Induces Cognitive Deficits and Cortical Beta-Amyloid Deposition in Mice via BACE1-Antisense Activation.

Authors:  Hong-Yi Zhao; Hui-Juan Wu; Jia-Lin He; Jian-Hua Zhuang; Zhen-Yu Liu; Liu-Qing Huang; Zhong-Xin Zhao
Journal:  CNS Neurosci Ther       Date:  2017-02-01       Impact factor: 5.243

3.  The challenges of dementia care in rural China.

Authors:  Shulin Chen; Lisa L Boyle; Yeates Conwell; Shuiyuan Xiao; Helen Fung Kum Chiu
Journal:  Int Psychogeriatr       Date:  2014-05-20       Impact factor: 3.878

4.  Comorbidity Burden of Dementia: A Hospital-Based Retrospective Study from 2003 to 2012 in Seven Cities in China.

Authors:  Qing-Hua Wang; Xin Wang; Xian-Le Bu; Yan Lian; Yang Xiang; Hong-Bo Luo; Hai-Qiang Zou; Jie Pu; Zhong-He Zhou; Xiao-Ping Cui; Qing-Song Wang; Xiang-Qun Shi; Wei Han; Qiang Wu; Hui-Sheng Chen; Hang Lin; Chang-Yue Gao; Li-Li Zhang; Zhi-Qiang Xu; Meng Zhang; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Neurosci Bull       Date:  2017-11-13       Impact factor: 5.203

Review 5.  The efficacy of statins in the treatment of Alzheimer's disease: a meta-analysis of randomized controlled trial.

Authors:  Kun Xuan; Tianming Zhao; Guangbo Qu; Haixia Liu; Xin Chen; Yehuan Sun
Journal:  Neurol Sci       Date:  2020-01-13       Impact factor: 3.307

6.  Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway.

Authors:  Leilei Mao; Tuo Yang; Xin Li; Xia Lei; Yang Sun; Yongfang Zhao; Wenting Zhang; Yanqin Gao; Baoliang Sun; Feng Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-13       Impact factor: 6.200

Review 7.  Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.

Authors:  Yunhua Peng; Peipei Gao; Le Shi; Lei Chen; Jiankang Liu; Jiangang Long
Journal:  Antioxid Redox Signal       Date:  2020-03-16       Impact factor: 8.401

Review 8.  The Government's role in regulating, coordinating, and standardizing the response to Alzheimer's disease: Anticipated international cooperation in the area of intractable and rare diseases.

Authors:  Qi Tang; Peipei Song; Lingzhong Xu
Journal:  Intractable Rare Dis Res       Date:  2016-11

9.  The role of the Montreal Cognitive Assessment (MoCA) and its memory tasks for detecting mild cognitive impairment.

Authors:  Xudong Li; Shuhong Jia; Zhi Zhou; Yi Jin; Xiangfei Zhang; Chunlei Hou; Wenjing Zheng; Pei Rong; Jinsong Jiao
Journal:  Neurol Sci       Date:  2018-03-17       Impact factor: 3.307

10.  Estrogen receptor beta polymorphisms and cognitive performance in women: associations and modifications by genetic and environmental influences.

Authors:  Karin Fehsel; Tamara Schikowski; Michaela Jänner; Anke Hüls; Mohammed Voussoughi; Thomas Schulte; Andrea Vierkötter; Tom Teichert; Christian Herder; Dorothea Sugiri; Ursula Krämer; Christian Luckhaus
Journal:  J Neural Transm (Vienna)       Date:  2016-09-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.